{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:11:19Z","timestamp":1770066679511,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.clindermatol.2007.03.012","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T19:36:50Z","timestamp":1181245010000},"page":"341-346","source":"Crossref","is-referenced-by-count":28,"title":["Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts"],"prefix":"10.1016","volume":"25","author":[{"given":"Nadera J.","family":"Sweiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2007.03.012_bib1","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/316552a0","article-title":"Identity of tumour necrosis factor and the macrophage-secreted factor cachectin","volume":"316","author":"Beutler","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib3","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0091-6749(93)90352-G","article-title":"Increased secretion of tumor necrosis factor\u2013alpha, interleukin\u20131-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis","volume":"91","author":"Steffen","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib5","first-page":"421","article-title":"Tumor necrosis factor production by human sarcoid alveolar macrophages","volume":"125","author":"Bachwich","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib6","first-page":"36","article-title":"Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis","volume":"115","author":"Baughman","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM198108203050804","article-title":"Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity","volume":"305","author":"Hunninghake","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib8","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis","volume":"361","author":"Baughman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/ajrccm\/144.4.861","article-title":"Antigen-induced proliferative response of lavage and blood T lymphocytes. Comparison of cells from normal subjects and patients with sarcoidosis","volume":"144","author":"Lecossier","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib11","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor\u2013alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib14","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00063030-200317060-00005","article-title":"Tumour necrosis factor in sarcoidosis and its potential for targeted therapy","volume":"17","author":"Baughman","year":"2003","journal-title":"BioDrugs"},{"issue":"6 Pt 1","key":"10.1016\/j.clindermatol.2007.03.012_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1164\/ajrccm\/142.6_Pt_1.1268","article-title":"The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis","volume":"142","author":"Baughman","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1183\/09031936.99.14511179","article-title":"Treatment of chronic sarcoidosis with an azathioprine\/prednisolone regimen","volume":"14","author":"Muller-Quernheim","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","article-title":"Cellular and molecular regulation of tumor necrosis factor\u2013alpha production by pentoxifylline","volume":"155","author":"Strieter","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03401576","article-title":"Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis","volume":"1","author":"Tramontana","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0954-6111(97)90134-7","article-title":"Thalidomide reduces tumour necrosis factor\u2013alpha production by human alveolar macrophages","volume":"91","author":"Tavares","year":"1997","journal-title":"Respir Med"},{"issue":"5 Suppl 1","key":"10.1016\/j.clindermatol.2007.03.012_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.semarthrit.2005.01.003","article-title":"Differentiating the efficacy of the tumor necrosis factor inhibitors","volume":"34","author":"Haraoui","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib22","first-page":"24","article-title":"Cells and cytokines involved in the pathogenesis of sarcoidosis","volume":"16","author":"Moller","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2249.2003.02105.x","article-title":"Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis","volume":"132","author":"Shigehara","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1189\/jlb.1202628","article-title":"High expression of p21 Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation","volume":"74","author":"Xaus","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2036.2005.02309.x","article-title":"Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept","volume":"21","author":"Shen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1378\/chest.128.2.1062","article-title":"Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial","volume":"128","author":"Baughman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/art.20936","article-title":"Chronic sarcoid arthritis treated with intraarticular etanercept","volume":"52","author":"Hobbs","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.clindermatol.2007.03.012_bib28","first-page":"S121","article-title":"TNF-inhibition as novel treatment for refractory sarcoidosis","volume":"9","author":"Sweiss","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib29","first-page":"1864","article-title":"Etanercept ameliorates sarcoidosis arthritis and skin disease","volume":"30","author":"Khanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib31","first-page":"70","article-title":"Infliximab for refractory sarcoidosis","volume":"8","author":"Baughman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","article-title":"Treatment of complicated sarcoidosis with infliximab anti\u2013tumor necrosis factor alpha therapy","volume":"135","author":"Yee","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/01.WNL.0000034766.13282.33","article-title":"Refractory neurosarcoidosis responding to infliximab","volume":"59","author":"Pettersen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mjd.2003.228","article-title":"Progressive cutaneous sarcoidosis responding to anti\u2013tumor necrosis factor alpha therapy","volume":"48","author":"Mallbris","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/archneur.60.3.426","article-title":"The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximab","volume":"60","author":"Katz","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib36","first-page":"413","article-title":"The use of infliximab in cutaneous sarcoidosis","volume":"2","author":"Meyerle","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib37","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1378\/chest.124.5.2028","article-title":"Refractory sarcoidosis responding to infliximab","volume":"124","author":"Roberts","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2133.2004.05769.x","article-title":"Infliximab therapy for sarcoidosis (lupus pernio)","volume":"150","author":"Haley","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2002.004226","article-title":"Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients","volume":"63","author":"Pritchard","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.amjmed.2004.03.013","article-title":"Refractory neurosarcoidosis: a dramatic response to infliximab","volume":"117","author":"Carter","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00415-004-0432-1","article-title":"Successful treatment of steroid-refractory neurosarcoidosis with infliximab","volume":"251","author":"Sollberger","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00128071-200405060-00003","article-title":"Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents","volume":"5","author":"Baughman","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.ajkd.2004.10.011","article-title":"Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy","volume":"45","author":"Thumfart","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","volume":"127","author":"Doty","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archderm.141.7.910","article-title":"Recalcitrant cutaneous sarcoidosis responding to infliximab","volume":"141","author":"Heffernan","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2002-36522","article-title":"Therapy for extrapulmonary sarcoidosis","volume":"23","author":"Baughman","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/art.21468","article-title":"Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis","volume":"53","author":"Sweiss","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib48","unstructured":"Sweiss NJ, Curran JJ, Ellman MH. TNF inhibition as novel treatment for refractory sarcoidosis. ACR 69th Annual Scientific Meeting. Arthritis Rheum (Suppl) Sep."},{"key":"10.1016\/j.clindermatol.2007.03.012_bib49","article-title":"C-reactive protein as a predictor of infliximab treatment outcome in patients with chronic sarcoidosis. Annual Scientific Meeting. Late breaking abstract","volume":"52","author":"Sweiss","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2005.02.023","article-title":"Ulcerative cutaneous sarcoidosis responding to adalimumab","volume":"53","author":"Philips","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib51","first-page":"1","article-title":"Treatment of therapy-resistant sarcoidosis with adalimumab","author":"Callejas-Rubio","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.142.1.17","article-title":"Adalimumab for treatment of cutaneous sarcoidosis","volume":"142","author":"Heffernan","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib53","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2174\/092986705774462851","article-title":"Inhibitors of TACE and Caspase-1 as anti-inflammatory drugs","volume":"12","author":"Le","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib54","doi-asserted-by":"crossref","DOI":"10.1159\/000089815","article-title":"Successful treatment of sarcoidosis associated pulmonary hypertension with Bosentan","author":"Foley","year":"2005","journal-title":"Respiration"},{"key":"10.1016\/j.clindermatol.2007.03.012_bib55","article-title":"Sarcoidosis: past, present, and future concepts","volume":"4","author":"Geraint","year":"1986","journal-title":"Clin Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X07000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X07000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T20:34:08Z","timestamp":1556483648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X07000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0738081X07000661"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2007.03.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}